Table 2.
Association between epinephrine, sex, age, hemorrhage, and complications across the intervention and control groups
| Variable | Control group with epinephrine (N = 74) F (%) |
Intervention group without epinephrine (N = 39) F (%) |
χ | P |
|---|---|---|---|---|
| Sex | 6.26 | 0.016 | ||
| Male | 5 (6.8) | 9 (23.0) | ||
| Female | 69 (93.2) | 30 (77.0) | ||
| Hemorrhage | 0.104 | 0.949 | ||
| <50 cc | 47 (63.5) | 25 (64.1) | ||
| 50–100 cc | 20 (27.0) | 11 (28.2) | ||
| >100 cc | 7 (9.5) | 3 (7.7) | ||
| Complications | 9.92 | 0.019 | ||
| Arrhythmia | 1 (2.6) | 0 (0.0) | ||
| Hypertension | 1 (2.5) | 0 (0.0) | ||
| None | 74 (100.0) | 34 (87.1) | ||
| Both | 0 (0.0) | 3 (7.7) | ||
| Age [N, M ± SD, t (df)] | [74, 25.7 ± 7.3, 0.581 (111)] | [39, 24.9 ± 7.3, 0.583 (77)] | 0.562 | |
| Duration [N, M ± SD, t (df)] | [74, 149.8 ± 22.6, 7.88 (111)] | [39, 113.7 ± 23.9, 7.75 (74)] | 0.001 |